148 related articles for article (PubMed ID: 10326794)
1. Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas.
Walker RA; Dearing SJ
Breast Cancer Res Treat; 1999 Jan; 53(2):167-76. PubMed ID: 10326794
[TBL] [Abstract][Full Text] [Related]
2. Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.
Levesque MA; Clark GM; Yu H; Diamandis EP
Br J Cancer; 1995 Sep; 72(3):720-7. PubMed ID: 7545416
[TBL] [Abstract][Full Text] [Related]
3. Relations between epidermal growth factor receptor and oestrogen and progesterone receptors in breast cancers of premenopausal and postmenopausal patients in Kuwait.
Nasralla MY; Paszko Z; Omar YT; Ali MA; al Jazzaf H; Padzik H; Temmim L
Eur J Cancer; 1992; 29A(1):76-81. PubMed ID: 1445750
[TBL] [Abstract][Full Text] [Related]
4. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
Kommoss F; Colley M; Hart CE; Franklin WA
Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemistry and in situ hybridisation of epidermal growth factor receptor and relation to prognostic factors in breast cancer.
Bilous M; Milliken J; Mathijs JM
Eur J Cancer; 1992; 28A(6-7):1033-7. PubMed ID: 1320909
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay.
Pawlowski V; Révillion F; Hebbar M; Hornez L; Peyrat JP
Clin Cancer Res; 2000 Nov; 6(11):4217-25. PubMed ID: 11106235
[TBL] [Abstract][Full Text] [Related]
7. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
[TBL] [Abstract][Full Text] [Related]
9. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast.
Barker S; Panahy C; Puddefoot JR; Goode AW; Vinson GP
Br J Cancer; 1989 Nov; 60(5):673-7. PubMed ID: 2803944
[TBL] [Abstract][Full Text] [Related]
11. Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer.
Gaedcke J; Traub F; Milde S; Wilkens L; Stan A; Ostertag H; Christgen M; von Wasielewski R; Kreipe HH
Mod Pathol; 2007 Aug; 20(8):864-70. PubMed ID: 17541441
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents.
Gotteland M; May E; May-Levin F; Contesso G; Delarue JC; Mouriesse H
Cancer; 1994 Aug; 74(3):864-71. PubMed ID: 7913659
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
Henzen-Logmans SC; Fieret EJ; Berns EM; van der Burg ME; Klijn JG; Foekens JA
Int J Cancer; 1994 May; 57(4):468-72. PubMed ID: 8181851
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations.
Hanley KZ; Birdsong GG; Cohen C; Siddiqui MT
Cancer; 2009 Aug; 117(4):279-88. PubMed ID: 19551847
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
Iwase H; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Toyama T; Hara Y; Kobayashi S
Cancer Detect Prev; 1997; 21(1):29-35. PubMed ID: 9043760
[TBL] [Abstract][Full Text] [Related]
18. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
[TBL] [Abstract][Full Text] [Related]
19. C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.
Looi LM; Cheah PL
Malays J Pathol; 1998 Jun; 20(1):19-23. PubMed ID: 10879259
[TBL] [Abstract][Full Text] [Related]
20. Detection of oestrogen and progesterone receptor expression in breast tumors by semiquantitative PCR.
Hackl T; Zickl M; Dobianer K; Hruza C; Czerwenka K; Spona J
Anticancer Res; 1998; 18(2A):839-42. PubMed ID: 9615729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
